212 related articles for article (PubMed ID: 33399095)
1. Prognostic alternative splicing signature in cervical squamous cell carcinoma.
Wu HY; Li QQ; Liang L; Qiu LL; Wei HW; Huang BY; Gang- C; He RQ; Huang ZG; Hou W; Hu QP; Pan SL
IET Syst Biol; 2020 Dec; 14(6):314-322. PubMed ID: 33399095
[TBL] [Abstract][Full Text] [Related]
2. Identification of
Zhao S; Yu M
DNA Cell Biol; 2020 Feb; 39(2):255-272. PubMed ID: 31977248
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
[TBL] [Abstract][Full Text] [Related]
4. Characterization of alternative splicing events and prognostic signatures in breast cancer.
Han P; Zhu J; Feng G; Wang Z; Ding Y
BMC Cancer; 2021 May; 21(1):587. PubMed ID: 34022836
[TBL] [Abstract][Full Text] [Related]
5. Identification of Key Genes in Association with Progression and Prognosis in Cervical Squamous Cell Carcinoma.
Meng H; Liu J; Qiu J; Nie S; Jiang Y; Wan Y; Cheng W
DNA Cell Biol; 2020 May; 39(5):848-863. PubMed ID: 32202912
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Alternative Splicing Genes in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Wang X; Tang W; Lu Y; You J; Han Y; Zheng Y
Int J Gen Med; 2021; 14():7933-7949. PubMed ID: 34785939
[TBL] [Abstract][Full Text] [Related]
7. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
[TBL] [Abstract][Full Text] [Related]
8. Identification of an immune-based mRNA-lncRNA signature for overall survival in cervical squamous cell carcinoma.
Mao Y; Chen R; Xia M; Guo P; Zeng F; Huang J; He M
Future Oncol; 2021 Jun; 17(18):2365-2380. PubMed ID: 33724869
[TBL] [Abstract][Full Text] [Related]
9. Uncovering of potential molecular markers for cervical squamous cell carcinoma (CESC) based on analysis of methylated-differentially expressed genes.
Liu M; Wei D; Nie Q; Peng L; He L; Cui Y; Ye Y
Taiwan J Obstet Gynecol; 2022 Jul; 61(4):663-671. PubMed ID: 35779918
[TBL] [Abstract][Full Text] [Related]
10. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in CESC.
Song J; Ye A; Jiang E; Yin X; Chen Z; Bai G; Zhou Y; Liu J
J Cell Biochem; 2018 Aug; 119(8):6665-6673. PubMed ID: 29741786
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of ferroptosis pathway gene signature and correlation with macrophage infiltration in cervical squamous cell carcinoma.
Li CJ; Chang CH; Tsang YL; Fang SH; Chen SN; Chiang AJ
Int Immunopharmacol; 2022 Nov; 112():109273. PubMed ID: 36183678
[TBL] [Abstract][Full Text] [Related]
12. Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis.
Liu J; Nie S; Gao M; Jiang Y; Wan Y; Ma X; Zhou S; Cheng W
J Cell Physiol; 2019 Nov; 234(11):21260-21273. PubMed ID: 31041817
[TBL] [Abstract][Full Text] [Related]
13. Screening of Significant Biomarkers Related to Prognosis of Cervical Cancer and Functional Study Based on lncRNA-associated ceRNA Regulatory Network.
Ding H; Zhang L; Zhang C; Song J; Jiang Y
Comb Chem High Throughput Screen; 2021; 24(3):472-482. PubMed ID: 32729415
[TBL] [Abstract][Full Text] [Related]
14. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
15. Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data.
Wu HY; Peng ZG; He RQ; Luo B; Ma J; Hu XH; Dang YW; Chen G; Pan SL
Int J Oncol; 2019 Aug; 55(2):425-438. PubMed ID: 31268164
[TBL] [Abstract][Full Text] [Related]
16. Identification of a 26-lncRNAs Risk Model for Predicting Overall Survival of Cervical Squamous Cell Carcinoma Based on Integrated Bioinformatics Analysis.
Mao Y; Fu Z; Dong L; Zheng Y; Dong J; Li X
DNA Cell Biol; 2019 Apr; 38(4):322-332. PubMed ID: 30698466
[TBL] [Abstract][Full Text] [Related]
17. Systematic Profile Analysis of Prognostic Alternative Messenger RNA Splicing Signatures and Splicing Factors in Head and Neck Squamous Cell Carcinoma.
Xing L; Zhang X; Tong D
DNA Cell Biol; 2019 Jul; 38(7):627-638. PubMed ID: 31025877
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F
Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732
[TBL] [Abstract][Full Text] [Related]
19. The New Biomarker for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Based on Public Database Mining.
Ding H; Xiong XX; Fan GL; Yi YX; Chen YR; Wang JT; Zhang W
Biomed Res Int; 2020; 2020():5478574. PubMed ID: 32351997
[TBL] [Abstract][Full Text] [Related]
20. Profiles of prognostic alternative splicing signature in hepatocellular carcinoma.
Wu F; Chen Q; Liu C; Duan X; Hu J; Liu J; Cao H; Li W; Li H
Cancer Med; 2020 Mar; 9(6):2171-2180. PubMed ID: 31975560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
